Terumo Corp
TSE:4543

Watchlist Manager
Terumo Corp Logo
Terumo Corp
TSE:4543
Watchlist
Price: 3 073 JPY 1.15% Market Closed
Market Cap: 4.6T JPY
Have any thoughts about
Terumo Corp?
Write Note

Terumo Corp
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Terumo Corp
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Terumo Corp
TSE:4543
Income from Continuing Operations
ÂĄ119.5B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
13%
Olympus Corp
TSE:7733
Income from Continuing Operations
ÂĄ28.3B
CAGR 3-Years
-31%
CAGR 5-Years
-4%
CAGR 10-Years
2%
Sysmex Corp
TSE:6869
Income from Continuing Operations
ÂĄ53.5B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
8%
Nihon Kohden Corp
TSE:6849
Income from Continuing Operations
ÂĄ14B
CAGR 3-Years
-14%
CAGR 5-Years
7%
CAGR 10-Years
2%
JEOL Ltd
TSE:6951
Income from Continuing Operations
ÂĄ25.1B
CAGR 3-Years
66%
CAGR 5-Years
34%
CAGR 10-Years
20%
Fukuda Denshi Co Ltd
TSE:6960
Income from Continuing Operations
ÂĄ18.2B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
11%
No Stocks Found

Terumo Corp
Glance View

Market Cap
4.6T JPY
Industry
Health Care

Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, has carved a significant niche in the global healthcare landscape as a leader in medical technology. With a steadfast commitment to enhancing the quality of life, Terumo focuses on innovative solutions in areas such as blood management, cardiovascular interventions, and surgical devices. Through a history of groundbreaking research and development, Terumo has established a robust portfolio of products that not only meet immediate clinical needs but also pave the way for advancements in patient care. The company’s dedication to sustainability and social responsibility further solidifies its reputation as a trustworthy and forward-thinking organization committed to making a positive impact on society. For investors, Terumo presents an attractive opportunity characterized by steady growth, a diverse global presence, and a solid financial foundation. The company's strategic focus on expanding its international footprint, particularly in emerging markets, positions it to capitalize on the rising demand for healthcare innovations. With an increasingly aging population and a growing emphasis on preventative care and advanced treatments, Terumo's comprehensive array of products is well-placed to address these market dynamics. As it continues to invest in R&D and forge strategic partnerships, Terumo Corporation not only stands as a resilient player in the medical technology sector but also as a company poised for long-term growth and value creation for its shareholders.

Intrinsic Value
2 428.38 JPY
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Terumo Corp's Income from Continuing Operations?
Income from Continuing Operations
119.5B JPY

Based on the financial report for Sep 30, 2024, Terumo Corp's Income from Continuing Operations amounts to 119.5B JPY.

What is Terumo Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
13%

Over the last year, the Income from Continuing Operations growth was 21%. The average annual Income from Continuing Operations growth rates for Terumo Corp have been 8% over the past three years , 6% over the past five years , and 13% over the past ten years .

Back to Top